Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. The company is headquartered in San Diego, California. Show more

4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO, CA, UNITED STATES, 92122, San Diego, CA, 92122, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

140.1M

52 Wk Range

$3.35 - $17.94

Previous Close

$5.32

Open

$5.46

Volume

152,451

Day Range

$5.42 - $6.44

Enterprise Value

25.23M

Cash

62.44M

Avg Qtr Burn

-18.87M

Insider Ownership

16.12%

Institutional Own.

56.08%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
ARD-101 Details Prader-Willi Syndrome	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ARD-201 (DPP-4 Combination) Details Obesity	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.